THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES. TORONTO, July 30, 2026 (GLOBE NEWSWIRE) — Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FSE: 0K91) (Upstream: QNTM) (“Quantum BioPharma” or the “Company”), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development, today announces the following corporate updates: The Company is pleased to announce that, further to its press release of July 20, 2026, it has closed the settlement of CAD$123,487.43 owing to arm’s length creditors and insiders of the Company...

Commercial Momentum Accelerates as Health System Adopts Turnkey Blood Volume Analysis via CLIA-Certified Send-Out Model OAK RIDGE, TN, July 29, 2026 (GLOBE NEWSWIRE) — Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, today announced the launch of a new outpatient Blood Volume Analysis (BVA™) program at a leading healthcare facility in eastern Kansas. This initiative expands Daxor’s presence in Midwestern outpatient care, giving regional clinicians direct access to objective volume metrics. The launch leverages Daxor’s turnkey ezBVA Lab send-out model, enabling outpatient practices to obtain 98% accurate, quantitative blood volume measurements within 24 hours—with zero capital equipment or dedicated lab infrastructure required. By directly measuring total blood, plasma, and red cell...

NI 43-101 compliant report supports previously announced PEA results for titanium and rare earths project VANCOUVER, British Columbia, July 29, 2026 (GLOBE NEWSWIRE) — Resouro Strategic Metals Inc. (TSX-V: RSM; ASX: RAU; OTCQB: RSGOF; FSE: 8TX) (“Resouro” or the “Company”) has filed an independent technical report (“Technical Report”) for the Tiros Titanium and Rare Earths Project (“Tiros Project”), located in Minas Gerais, Brazil. The Company previously disclosed the results of a preliminary economic assessment (“PEA”) on the Tiros Project in its June 14/15, 2026 news release and the Supplementary Information released on June 17, 2026 in response to ASX Listing Rule 5.16 requirements. “This report independently supports the strong technical and economic foundations of our staged development strategy,” said Christopher Eager,...

THE WOODLANDS, Texas, July 29, 2026 (GLOBE NEWSWIRE) — TWFG, Inc. (NASDAQ: TWFG), a leading independent insurance distribution platform, announced today that it will release its financial results for the second quarter ended June 30, 2026, after the market closes on Wednesday, August 5, 2026. The Company will host a conference call to discuss its financial results at 4:00 p.m. Central Time (5:00 p.m. Eastern Time) on Thursday, August 6, 2026. CLICK HERE TO ACCESS THE CALL BY WEBCAST TO REGISTER FOR ACCESS TO THE LIVE CONFERENCE CALL:Click on the link below and complete the online registration form. Upon registering you will receive the dial-in info and a unique PIN to join the call as well as an email confirmation with the details. Select a method for joining the call: Dial-In: A dial in number and unique PIN are displayed to...

Expanding indications for RYONCIL in children and adults with life-threatening inflammatory diseases Achieved target of at least 300 Patients treated in Pivotal Phase 3 trial for Chronic Low Back Pain Activity Report for Quarter Ended June 30, 2026 (Appendix 4C) NEW YORK, July 29, 2026 (GLOBE NEWSWIRE) — Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today provided highlights of its recent activities for the fourth fiscal quarter ended June 30, 2026. “We are very pleased with the continued momentum in uptake of Ryoncil® in children with life-threatening steroid-refractory acute GvHD across major U.S. pediatric centers, positioning the treatment well for use next in adults with this life-threatening disease. We will continue to build on the strong first full year...

VANCOUVER, British Columbia, July 29, 2026 (GLOBE NEWSWIRE) — Fortuna Mining Corp. (NYSE: FSM | TSX: FVI) is pleased to announce that it has approved the expansion of its Séguéla Gold Mine in Côte d’Ivoire. The project includes an expansion of the Séguéla processing facility, upgrades to supporting infrastructure, and development of the Sunbird underground mine. Together, these investments are expected to increase throughput, improve gold recoveries, accelerate production from Séguéla’s growing resource base, and reinforce the mine’s position as a cornerstone asset in Fortuna’s portfolio. Expansion Highlights30% increase in processing capacity, from 1.75 Mtpa to 2.3 Mtpa, with average gold recovery expected to reach 94.5% Expected to support average annual gold production at Séguéla of more than 200,000 ounces over the next decade Higher...

TORONTO, July 29, 2026 (GLOBE NEWSWIRE) — Sprott Asset Management LP (“Sprott Asset Management”), a wholly-owned subsidiary of Sprott Inc. (“Sprott”) (NYSE/TSX: SII), on behalf of the Sprott Physical Copper Trust (NYSE: SCOP) (TSX: COP.UN) (TSX: COP.U) (the “Trust”), a closed-ended mutual fund trust created to invest and hold substantially all of its assets in physical copper metal, today announced that it has updated its at-the-market equity program to issue up to U.S.$250 million of Units of the Trust (“Units”) in Canada and the United States (the “ATM Program”). This ATM Program replaces the Trust’s previous at-the-market equity program, announced on May 4, 2026, which has since been terminated. Distributions under the ATM Program will be completed in accordance with the terms of an amended and restated sales agreement (the...